Antibiotics | Free Full-Text | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Targeted Endolysin Whitepapers | Gladskin
Endolysin Science | Gladskin
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine
Targeted Endolysin Whitepapers | Gladskin
Gladskin: Revolutionizing Eczema Care & Restoring Skin Health
Micreos (@Micreos) / X
Endolysin Science | Gladskin
Antibiotics | Free Full-Text | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
Targeted Endolysin Whitepapers | Gladskin
Antibiotics | Free Full-Text | Endolysin, a Promising Solution against Antimicrobial Resistance
How to treat eczema: New breakthrough study proves certain products can improve quality of life
Micreos sidesteps antibiotic resistance, targeting superbugs with $37M for endolysin | 2021-10-04 | BioWorld
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Micreos
So Glad We Found Gladskin Eczema Cream - LimByLim
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
NEW STUDY: Gladskin ingredient Staphefekt™ found to significantly redu
Western blot analysis of endolysin accumulation in transgenic lines.... | Download Scientific Diagram
Antibiotics | Free Full-Text | Endolysin, a Promising Solution against Antimicrobial Resistance
The Advantages and Challenges of Using Endolysins in a Clinical Setting. - Abstract - Europe PMC
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Josephine Offerhaus posted on LinkedIn
Viruses | Free Full-Text | The Advantages and Challenges of Using Endolysins in a Clinical Setting
Pharmaceuticals | Free Full-Text | Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens
